Modulation of T lymphocyte replicative senescence via TNF-α inhibition: Role of caspase-3

Journal of Immunology

Volumn 182, Issue 7, 2009, Pages 4237-4243

  Parish, Stanley T ^a   Wu, Jennifer E ^a   Effros, Rita B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CD28 ANTIGEN; CYTOKINE; NEUTRALIZING ANTIBODY; TELOMERASE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA INHIBITOR; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; INTERLEUKIN 6;

ANTIGEN EXPRESSION; ARTICLE; CD8+ T LYMPHOCYTE; CELL AGING; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME ACTIVITY; GENE CONTROL; HUMAN; HUMAN CELL; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; BIOSYNTHESIS; CELL CULTURE; CELL PROLIFERATION; CYTOLOGY; DRUG ANTAGONISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; METABOLISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE SUBPOPULATION;

ANTIGENS, CD28; CASPASE 3; CD8-POSITIVE T-LYMPHOCYTES; CELL AGING; CELL PROLIFERATION; CELLS, CULTURED; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-6; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; T-LYMPHOCYTE SUBSETS; TELOMERASE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 64249117497     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0803449     Document Type: Article

References (47)

1. Lenschow, D. J., T. L. Walunas, and J. A. Bluestone. 1996. CD28/B7 system of T cell costimulation. Annu. Rev. Immunol. 14: 233-258.
2. Lindstein, T., C. H. June, J. A. Ledbetter, G. Stella, and C. B. Thompson. 1989. Regulation of lymphokine messenger RNA stability by a surface-mediated T cell activation pathway. Science 244: 339-343.
3. Powell, J. D., J. A. Ragheb, S. Kitagawa-Sakakida, and R. H. Schwartz. 1998. Molecular regulation of interleukin-2 expression by CD28 costimulation and anergy. Immunol. Rev. 165: 287-300.
4. Valenzuela, H. F., and R. B. Effros. 2002. Divergent telomerase and CD28 expression patterns in human CD4 and CD8 T cells following repeated encounters with the same antigenic stimulus. Clin. Immunol. 105: 117-125.
5. Posnett, D. N., R. Sinha, S. Kabak, and C. Russo. 1994. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammapathy". J. Exp. Med. 179: 609-618.
6. + T cells is associated with the loss of gene-specific nuclear factor binding activity. J. Biol. Chem. 273: 8119-8129.
7. Goronzy, J. J., J. W. Fulbright, C. S. Crowson, G. A. Poland, W. M. O'Fallon, and C. M. Weyand. 2001. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J. Virol. 75: 12182-12187.
8. - T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J. Immunol. 168: 5893-5899.
9. Hadrup, S. R., J. Strindhall, T. Kollgaard, T. Seremet, B. Johansson, G. Pawelec, P. thor Straten, and A. Wikby. 2006. Longitudinal studies of clonally expanded CD8 T cells reveal a repertoire shrinkage predicting mortality and an increased number of dysfunctional cytomegalovirus-specific T cells in the very elderly. J. Immunol. 176: 2645-2653.
10. + T cell subset and increase with loss of CD4 T cells. AIDS 13: 1029-1033.
11. Neil, G. A., R. W. Summers, B. A. Cheyne, C. Carpenter, W. L. Huang, and T. J. Waldschmidt. 1994. Analysis of T-lymphocyte subpopulations in inflammatory bowel diseases by three-color flow cytometry. Dig. Dis. Sci. 39: 1900-1908.
12. Moosig, F., E. Csernok, G. Wang, and W. L. Gross. 1998. Costimulatory molecules in Wegener's granulomatosis (WG): lack of expression of CD28 and preferential up-regulation of its ligands B7-1 (CD80) and B7-2 (CD86) on T cells. Clin. Exp. Immunol. 114: 113-118. (Pubitemid 28442822)
13. Dutra, W. O., O. A. Martins-Filho, J. R. Cancado, J. C. Pinto-Dias, Z. Brener, G. Gazzinelli, J. F. Carvalho, and D. G. Colley. 1996. Chagasic patients lack CD28 expression on many of their circulating T lymphocytes. Scand. J. Immunol. 43: 88-93.
14. - T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J. Clin. Invest. 97: 2027-2037.
15. Effros, R. B. 2004. From Hayflick to Walford: the role of T cell replicative senescence in human aging. Exp. Gerontol. 39: 885-890. (Pubitemid 38798525)
16. Vallejo, A. N., C. M. Weyand, and J. J. Goronzy. 2004. T-cell senescence: a culprit of immune abnormalities in chronic inflammation and persistent infection. Trends Mol. Med. 10: 119-124.
17. Bryl, E., A. N. Vallejo, E. L. Matteson, J. M. Witkowski, C. M. Weyand, and J. J. Goronzy. 2005. Modulation of CD28 expression with anti-tumor necrosis factor α therapy in rheumatoid arthritis. Arthritis Rheum. 52: 2996-3003. (Pubitemid 41447078)
18. Bryl, E., A. N. Vallejo, C. M. Weyand, and J. J. Goronzy. 2001. Down-regulation of CD28 expression by TNF-α. J. Immunol. 167: 3231-3238.
19. + T-cell replicative senescence in human aging. Immunol. Rev. 205: 147-157.
20. Vallejo, A. N. 2005. CD28 extinction in human T cells: altered functions and the program of T-cell senescence. Immunol. Rev. 205: 158-169.
21. Lewis, D. E., M. Merched-Sauvage, J. J. Goronzy, C. M. Weyand, and A. N. Vallejo. 2004. Tumor necrosis factor-α and CD80 modulate CD28 expression through a similar mechanism of T-cell receptor-independent inhibition of transcription. J. Biol. Chem. 279: 29130-29138.
22. Gupta, S. 2002. Tumor necrosis factor-α-induced apoptosis in T cells from aged humans: a role of TNFR-I and downstream signaling molecules. Exp. Gerontol. 37: 293-299. (Pubitemid 34073546)
23. Ma, S., H. Ochi, L. Cui, and W. He. 2003. FasL-induced downregulation of CD28 expression on Jurkat cells in vitro is associated with activation of caspases. Cell Biol. Int. 27: 959-964.
24. Micheau, O., and J. Tschopp. 2003. Induction of TNF receptor I-mediated apoptosis via two sequential signaling complexes. Cell 114: 181-190. (Pubitemid 36936912)
25. Ma, S., H. Ochi, L. Cui, J. Zhang, and W. He. 2003. Hydrogen peroxide induced down-regulation of CD28 expression of Jurkat cells is associated with a change of site α-specific nuclear factor binding activity and the activation of caspase-3. Exp. Gerontol. 38: 1109-1118.
26. Perillo, N. L., R. L. Walford, M. A. Newman, and R. B. Effros. 1989. Human T lymphocytes possess a limited in vitro life span. Exp. Gerontol. 24: 177-187.
27. + T cells: enhanced antiviral functions accompany the increased proliferative potential and telomere length stabilization. J. Immunol. 173: 6303-6311.
28. + and IL-6 in C3B10RF1 mice. Mech. Ageing Dev. 93: 87-94.
29. + T cells in centenarians and in long-term T cell cultures: a possible cause for both in vivo and in vitro immunosenescence. Exp. Gerontol. 29: 601-609.
30. + cell subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS 10: F17-F22.
31. Wallach, D., E. E. Varfolomeev, N. L. Malinin, Y. V. Goltsev, A. V. Kovalenko, and M. P. Boldin. 1999. Tumor necrosis factor receptor and Fas signaling mechanisms. Annu. Rev. Immunol. 17: 331-367. (Pubitemid 29241128)
32. Walker, L. S., J. D. McLeod, G. Boulougouris, Y. I. Patel, N. D. Hall, and D. M. Sansom. 1998. Down-regulation of CD28 via Fas (CD95): influence of CD28 on T-cell apoptosis. Immunology 94: 41-47.
33. Effros, R. B. 2004. Replicative senescence of CD8 T cells: effect on human ageing. Exp. Gerontol. 39: 517-524.
34. Rink, L., I. Cakman, and H. Kirchner. 1998. Altered cytokine production in the elderly. Mech. Ageing Dev. 102: 199-209.
35. Tarazona, R., O. DelaRosa, C. Alonso, B. Ostos, J. Espejo, J. Pena, and R. Solana. 2000. Increased expression of NK cell markers on T lymphocytes in aging and chronic activation of the immune system reflects the accumulation of effector/senescent T cells. Mech. Ageing Dev. 121: 77-88. (Pubitemid 32115402)
36. Effros, R. B., K. Svoboda, and R. L. Walford. 1991. Influence of age and caloric restriction on macrophage IL-6 and TNF production. Lymphokine Cytokine Res. 10: 347-351.
37. Fraser, J. D., B. A. Irving, G. R. Crabtree, and A. Weiss. 1991. Regulation of interleukin-2 gene enhancer activity by the T cell accessory molecule CD28. Science 251: 313-316.
38. Verweij, C. L., M. Geerts, and L. A. Aarden. 1991. Activation of interleukin-2 gene transcription via the T-cell surface molecule CD28 is mediated through an NF-κB-like response element. J. Biol. Chem. 266: 14179-14182.
39. + T lymphocytes. J. Immunol. 181: 7400-7406.
40. - compartment. Blood 98: 2817-2827.
41. + mature thymocytes. J. Immunol. 144: 1646-1653.
42. + T cells from HIV-infected subjects. Clin. Exp. Immunol. 100: 425-433.
43. - T-cell subset of effector cells in the circulation of patients with head and neck cancer. Cancer Immunol. Immunother. 52: 599-607.
44. Hakansson, A., L. Hakansson, B. Gustafsson, L. Krysander, B. Rettrup, D. Ruiter, and M. R. Bernsen. 2002. Biochemotherapy of metastatic malignant melanoma: on down-regulation of CD28. Cancer Immunol. Immunother. 51: 499-504.
45. Hayflick, L. 1965. The limited in vitro lifetime of human diploid cell strains. Exp. Cell Res. 37: 614-636.
46. Effros, R. B. 2007. Telomerase induction in T cells: a cure for aging and disease? Exp. Gerontol. 42: 416-420.
47. + T cells that reach replicative senescence after multiple rounds of antigenspecific proliferation. Exp. Gerontol. 34: 633-644.